Japan Biotech Forum: London
Licensing and partnering opportunities emerging from Japan
transB has hosted the Japan Biotech Forum in London for two years running, bringing a number of cherry-picked companies from Japan developing clinical stage products for licensing and investment opportunities.
transB is well placed to identify early stage Japanese biotech companies with licensing assets. We will be running the Forum again in the future and will be seeking commercial sponsors to make this possible. Please contact us if you would be interested in partnering with us.
 |
 |
| Networking session | Presentation by a Japanese biotech company |
Benefits of attending
- Presentations from senior representatives from Japanese biotech companies
- Insightful corporate and product analyses provided as handouts
- One-to-one partnering
- Efficient networking with delegates from the licensing and investment communities
Conference programmes
2010 conference programme 2009 conference programme
Delegate profile
The Japan Biotech Forum attracts around 100 targeted delegates, creating an intimate yet efficient forum for networking. Past delegates include senior representatives from companies such as:
| aRigen Pharmaceuticals | Apposite Capital | Astellas Pharma Europe | AstraZeneca |
| BTG | CanBas | Chiome Bioscience | Circassia |
| Coller Capital | Cytox | Daiichi Sankyo Development | Dainippon Sumitomo Pharma |
| Debiopharm | Domainex | Epistem | e-Therapeutics |
| GE Healthcare | GlaxoSmithKline | Grunenthal | Heptares Therapeutics |
| IP Group | Ipsen | ITOCHU Corporation | Japan Bioindustry Association |
| Kyowa Hakko Kirin | Lectus Therapeutics | LivTech | MebioPharm |
| Menarini Biotech | Mistubishi Tanabe | Mitsui & Co Europe | Mizuho Corporate Bank |
| MRC Technology | Norgine | Novartis | Novo Nordisk |
| Ono Pharma UK | Orion Corporation | Oxford Biomedica | Pfizer |
| Proximagen | RaQualia | Red Abbey Venture Partners | REGimmune |
| ReproCELL | Sentinel Oncology | Shanghai Fosun | Shire Pharmaceuticals |
| Siegfried | Sinclaire Pharma | Solasia | Sosei Group |
| Spirogen | Stiefel (GSK) | Takeda Pharmaceuticals | Teijin Pharma |
| Teva | UCB | Vecture Group | ZERIA Pharmaceuticals |
To download last year's delegates list, please click here.
Media coverage
Read about last year's conference from Thomson Reuters and the Japan Bioindustry Association. (Clicking on the links will open a PDF report.)
Contact
For any further enquiries on the Japan Biotech Forum, please contact Maki Aoyama at m.aoyama@transb.co.uk.